Report Categories
View AllRecent Articles
View All
Is REX REX stock ready for a move today REX notches 23 pct EPS beat vs analyst estimates
Fox Corporation FOX Options Volatility Signals Divergent Market Expectations Ahead of Fiscal Q3 2026 Earnings Release
The steady strength in Allied Gaming AGAE story Rallies 20260506
Claritev CTEV Stock Is It Forming a Reversal Q4 2025 Earnings Underperform
Scope for Meaningful Rate Cuts Ahead Says Credit Suisses Neelkanth Mishra
US Stocks Edge Higher as Chip Rally Continues Micron Surges 9 on AI Optimism
Traders Debate Potential Shift Away from Quarterly Earnings Reporting
Nio Shares Surge on Launch of First Flagship SUV in Over Two Years
Snowflake Stock Surges 36 on Earnings Beat and 6 Billion AWS Expansion Plan
UK Exports to US Plunge 25 Following Trump Tariff Blitz
NP Q1 2026 Earnings EPS Falls Short of Estimates Yet Stock Gains
PATH Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction
CMDB Q1 2026 Earnings Positive EPS Amid Quiet Market Reaction
Mativ Holdings MATV Q1 2026 Earnings EPS Surge of 194 Surprise Despite Flat Revenue Outlook
MAC Q1 2026 Earnings BottomLine Miss Weighs on Investor Sentiment
DJCO Q4 2025 Earnings Strong EPS of 3061 Highlights Profitability Amidst No Revenue Disclosure
Arrive AI Inc ARAI Holds Near Support After Minor Decline
ZenaTech ZENA Sees 382 Decline Tests Near Key Support at 132
Precigen Inc PGEN Tests Key Support as Bearish Pressure Persists Near 403
BILL Holdings Stock Slips as Market Weighs Growth Prospects Key Levels to Watch
Corteva CTVA Gains 114 as Stock Approaches Key Resistance Levels
Microbot Medical Inc MBOT Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Reaction
IE Q1 2026 Earnings EPS Misses Estimates Widely as Exploration Continues
SpaceX IPO Prospectus Highlights Starlinks Central Role in Revenue and Profit Growth
Trump and Senate Republican Tensions Political Risks Could Shape Policy Outlook for Investors
Pharming Group Q1 2026 Earnings Missed EPS Estimates Amid Operational Challenges
PTHS Q1 2026 Earnings Pelthos Therapeutics Surprises with NarrowerThanExpected Loss in Q1 2026